000			01473 a2200433 4500
005			20250513224743.0
264		0	_c20010126
008			200101s 0 0 eng d
022			_a0003-410X
040			_aNLM _beng _cNLM
100	1		_aPapapoulos, S E
245	0	0	_aBisphosphonates in the treatment of osteoporosis. Principles and efficacy. _h[electronic resource]
260			_bAnnales de medecine interne _cOct 2000
300			_a504-10 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdministration, Oral
650	0	4	_aAlendronate _xtherapeutic use
650	0	4	_aAnimals
650	0	4	_aBone Density
650	0	4	_aBone and Bones _xdrug effects
650	0	4	_aCalcium Channel Blockers _xtherapeutic use
650	0	4	_aControlled Clinical Trials as Topic
650	0	4	_aDiphosphonates _xadministration & dosage
650	0	4	_aEtidronic Acid _xanalogs & derivatives
650	0	4	_aFemale
650	0	4	_aHip Fractures _xprevention & control
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aOsteoporosis _xdrug therapy
650	0	4	_aOsteoporosis, Postmenopausal _xdrug therapy
650	0	4	_aPamidronate
650	0	4	_aPapio
650	0	4	_aProspective Studies
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRisedronic Acid
650	0	4	_aSpinal Fractures _xprevention & control
650	0	4	_aTime Factors
773	0		_tAnnales de medecine interne _gvol. 151 _gno. 6 _gp. 504-10
999			_c11046291 _d11046291